Dr Richard Russell
Head of Department, Peter Gorer Department of Immunobiology
- Clinical Reader
Biography
Dr Richard Russell is a the Head of Department, Peter Gorer Department of Immunobiology and a Clinical Reader in the School of Immunology & Microbial Sciences at King's College London.
Research
Clinical Diagnostics Development Unit (CDDU)
The CDDU ethos is to harmonise all methods used within the labs for the processing of clinical samples.
King's Centre for Lung Health
Promoting lung health throughout the lifetime, by preventing, diagnosing and treating lung disease.
News
People with COPD feel like 'second class citizens', finds new report
A report from King’s College London sets out the stark reality people with chronic obstructive pulmonary disease (COPD) face in securing diagnosis and...
First new treatment for asthma attacks in 50 years
An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further...
New heart disease calculator could save lives by identifying high-risk patients missed by current tools
The collaborative research, led from the University of Oxford, has developed a new tool that more accurately predicts risk of cardiovascular diseases
Research
Clinical Diagnostics Development Unit (CDDU)
The CDDU ethos is to harmonise all methods used within the labs for the processing of clinical samples.
King's Centre for Lung Health
Promoting lung health throughout the lifetime, by preventing, diagnosing and treating lung disease.
News
People with COPD feel like 'second class citizens', finds new report
A report from King’s College London sets out the stark reality people with chronic obstructive pulmonary disease (COPD) face in securing diagnosis and...
First new treatment for asthma attacks in 50 years
An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further...
New heart disease calculator could save lives by identifying high-risk patients missed by current tools
The collaborative research, led from the University of Oxford, has developed a new tool that more accurately predicts risk of cardiovascular diseases